Browse Items (7 total)

• 

  After the Ebola Outbreak: Lessons Learned

  Tags Critical Care, Ebola, Experimental Drugs, Follow up, Infection Prevention and Control, Nursing, Patient Care, Personal Protective Equipment (PPE), Prophylaxis, R-PPE, Survivors, Therapeutics, Training, Translational Research
  Creator: Loftus, Mary (editor), Emory Medicine
  Subject: General
  Item Type: Hyperlink
  Date Last Updated: 2018-02-20
  Description: In the wake of caring for four patients with active Ebola virus in 2014, Emory clinicians have taken stock of lessons learned in infectious disease prevention, therapeutic care, and health aftereffects and are sharing that information broadly with…
• 

  Prioritizing diseases for research and development in emergency contexts

  Tags Coronavirus, Crimean Congo Haemorrhagic Fever (CCHF), Ebola, Epidemic, Experimental Drugs, Lassa, Marburg, Medical Surveillance, MERS-CoV, Mpox, Orthopox Virus, Outbreaks, Pandemic, Plague, Prophylaxis, Public Health, R-Gen, Respiratory Pathogen, SARS, Special Pathogens, Therapeutics, Vaccine Study, Variola, Viral Hemorrhagic Fever
  Creator: World Health Organization
  Subject: General
  Item Type: Guide
  Date Last Updated: 2022
  Description: Worldwide, the number of potential pathogens is very large, while the resources for disease research and development (R&D) is limited. To ensure efforts under WHO’s R&D Blueprint are focused and productive, a list of diseases and pathogens are…

• Are We Ready for the Next Outbreak?

  Tags Ebola, Epidemic, Epidemiology, Experimental Drugs, Federal, International Response, Medical Surveillance, Outbreaks, Pandemic, Prophylaxis, Public Health, R-Gen
  Creator: U.S. Agency for International Development
  Subject: General
  Item Type: Webinar
  Date Last Updated: 2018-04-01
  Description: A three part pod-cast series discusses the need for new and improved tools to fight infectious disease, as demonstrated by the recent outbreaks of Ebola and Zika.
• 

  Editorial Commentary: Considerations of Favipiravir as a Medical Countermeasure in Future Randomized Controlled Trials Against Ebola Virus Disease

  Tags Clinical Trial, Ebola, Experimental Drugs, Patient Care, R-Res&Pub, Therapeutics
  Creator: Kraft, C. S.
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2016-11-15
  Description: Since the discovery of Ebola virus in the Democratic Republic of Congo in 1976, outbreaks of EVD had been mainly confined to rural areas (http://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html)...
• 

  The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States

  Tags Critical Care, Ebola, Experimental Drugs, Patient Care, R-Res&Pub, Therapeutics
  Creator: Kraft, C. S., A. L. Hewlett, S. Koepsell, A. M. Winkler, C. J. Kratochvil, L. Larson, J. B. Varkey, A. K. Mehta, G. M. Lyon, 3rd, R. J. Friedman-Moraco, V. C. Marconi, C. E. Hill, J. N. Sullivan, D. W. Johnson, S. J. Lisco, M. J. Mulligan, T. M.…
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2015-08-15
  Description: The current West Africa Ebola virus disease (EVD) outbreak has resulted in multiple individuals being medically evacuated to other countries for clinical management.

• A Novel Approach to Infectious Disease Preparedness: Incorporating Investigational Therapeutics and Research Objectives into Full-Scale Exercises

  Tags Exercises and Drills, Experimental Drugs, R-Res&Pub, Research, Therapeutics
  Creator: Angela Vasa, Syra Madad, LuAnn Larson, Colleen S. Kraft, Sharon Vanairsdale, Jonathan D. Grein, Jennifer Garland, Virginia “Madison” Butterworth, and Christopher J. Kratochvil.
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2019-02-19
  Description: The use of investigational therapeutics in the care of patients with Ebola virus disease was documented in the literature following the 2013-2016 outbreak. In order to access these types of therapeutics, facilities must have processes in place to…

• Products Approved for Other Bioterrorism Emergencies

  Tags Coronavirus, Ebola, Experimental Drugs, MERS-CoV, Orthopox Virus, Plague, Prophylaxis, R-T&C, Respiratory Pathogen, Smallpox, Special Pathogens, Therapeutics, Viral Hemorrhagic Fever
  Creator: U.S. Food and Drug Administration
  Subject: Treatment & Care
  Item Type: Guide
  Date Last Updated: 2017-09-08
  Description: This site lists products for Botulism due to Clostridium botulinum toxin; Ebola Virus Disease (EVD); Glanders and Melioidosis due to Burkholderia mallei and B. pseudomallei, respectively; Plague due to Yersinia pestis; Smallpox due to Variola major…